Joseph Barker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Joseph Barker has a total of 164 co-authors. Here are the top co-authors by number of shared publications:
David Koeckerling
Division of Angiology, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, University of Bern , Bern , Switzerland
8 shared publications- Ghulam AndrÉ Ng
Department of Cardiovascular Sciences, Clinical Science Wing, Glenfield Hospital, University of Leicester, Leicester LE3 9QP, UK
7 shared publications - Daniel Pan
Department of Respiratory Sciences, University of Leicester, Leicester, UK
6 shared publications - Fu Siong Ng
Imperial College London
6 shared publications - Ibrahim Antoun
Department of Cardiovascular Sciences, Clinical Science Wing, University of Leicester, Glenfield Hospital, Leicester, UK
5 shared publications Oluwatobiloba Oyefeso
Hammersmith and Fulham Partnership, North End Medical Centre, London, UK
4 shared publications
Latest Publications
- Open Access
- 26 October 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
- Vol. 7 (10)
Digital virtual ward vs. standard of care for acute atrial fibrillation: a single centre non-randomized pilot comparison of clinical outcomes and cost
Aims: Atrial fibrillation (AF) incurs significant healthcare costs, mainly from acute hospitalizations. Digitally enabled models could provide hospital-level care at home for selected patients, but evidence in acute care remains inconsistent. Methods and results: In a propensity score-matched, non-randomized comparative study using real-world data (January–December 2022). Adults with acute AF admitted to the AF virtual ward (AFVW) were matched 1:1 to standard-of-care (SOC) inpatients meeting AFVW eligibility criteria. The primary outcome was a composite of emergency readmissions, urgent care attendance, or death within 90 days. A separate cost analysis was undertaken from the National Health Service secondary care perspective. Ninety-one AFVW patients were matched to 91 SOC patients. The primary outcome did not differ at 90 days (HR 0.61, 95% CI 0.34–1.10). Emergency bed-day use following readmission was higher in AFVW cohort (0.42 vs. 0.07 per spell; ratio 6.04; 95% CI 2.70–15.90), although the readmission rate itself was similar (7.7% vs. 7.0%). Thirty-day emergency attendances, outpatient appointments, and mortality were similar. In a separate, clinically screened but non-propensity-matched population (75 AFVW, 315 SOC patients), mean direct secondary-care cost per patient was £948 vs. £1,631, an adjusted saving of £642. Friends and Family Test respondents rated the AFVW positively. Conclusion: We found no significant difference in adverse outcomes between an acute AFVW and matched SOC, but the study was not powered for non-inferiority, and downstream emergency bed-day use was higher in the virtual ward arm. AFVW costs were lower in an exploratory analysis. These findings require confirmation in future studies.
- 26 October 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
- Vol. 7 (10)
Open AccessDigital virtual ward vs. standard of care for acute atrial fibrillation: a single centre non-randomized pilot comparison of clinical outcomes and cost
Aims: Atrial fibrillation (AF) incurs significant healthcare costs, mainly from acute hospitalizations. Digitally enabled models could provide hospital-level care at home for selected patients, but evidence in acute care remains inconsistent. Methods and results: In a propensity score-matched, non-randomized comparative study using real-world data (January–December 2022). Adults with acute AF admitted to the AF virtual ward (AFVW) were matched 1:1 to standard-of-care (SOC) inpatients meeting AFVW eligibility criteria. The primary outcome was a composite of emergency readmissions, urgent care attendance, or death within 90 days. A separate cost analysis was undertaken from the National Health Service secondary care perspective. Ninety-one AFVW patients were matched to 91 SOC patients. The primary outcome did not differ at 90 days (HR 0.61, 95% CI 0.34–1.10). Emergency bed-day use following readmission was higher in AFVW cohort (0.42 vs. 0.07 per spell; ratio 6.04; 95% CI 2.70–15.90), although the readmission rate itself was similar (7.7% vs. 7.0%). Thirty-day emergency attendances, outpatient appointments, and mortality were similar. In a separate, clinically screened but non-propensity-matched population (75 AFVW, 315 SOC patients), mean direct secondary-care cost per patient was £948 vs. £1,631, an adjusted saving of £642. Friends and Family Test respondents rated the AFVW positively. Conclusion: We found no significant difference in adverse outcomes between an acute AFVW and matched SOC, but the study was not powered for non-inferiority, and downstream emergency bed-day use was higher in the virtual ward arm. AFVW costs were lower in an exploratory analysis. These findings require confirmation in future studies.
- Open Access
- 29 July 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (8)
Artificial intelligence-enhanced electrocardiography for prediction of cancer therapy-related cardiac dysfunction
- 29 July 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (8)
Open AccessArtificial intelligence-enhanced electrocardiography for prediction of cancer therapy-related cardiac dysfunction
- Open Access
- 22 July 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
- Vol. 7 (7)
Artificial intelligence-enhanced electrocardiography for the prediction of future type 2 diabetes mellitus: a model-development and multicentre validation study
Aims: A significant proportion of type 2 diabetes cases remain undiagnosed despite screening advances, carrying substantial cardiometabolic risk. Artificial intelligence-enhanced electrocardiography (AI-ECG) detects subtle ECG changes in subclinical disease, potentially enabling opportunistic screening. Methods and results: We developed AI-ECG Risk Estimator for Diabetes Mellitus (AIRE-DM), a convolutional neural network with discrete-time survival loss, for diagnosis of prevalent and prediction of incident type 2 diabetes. It was trained on 1 163 401 ECGs from 189 537 individuals from Beth Israel Deaconess Medical Center (BIDMC) and externally validated in UK Biobank (UKB; n = 65 606) and ELSA-Brasil (n = 13 739). AI-ECG Risk Estimator for Diabetes Mellitus demonstrated moderate discrimination for prevalent type 2 diabetes (area under the receiver operating characteristic curve: BIDMC 0.724, UKB 0.733, ELSA-Brasil 0.706) and incident type 2 diabetes (C-index: BIDMC 0.667, UKB 0.688, ELSA-Brasil 0.625). The highest AIRE-DM risk quartile had elevated incident diabetes risk vs. the lowest (hazard ratio: BIDMC 4.75, UKB 7.52, ELSA-Brasil 3.96). AI-ECG Risk Estimator for Diabetes Mellitus was non-inferior to the American Diabetes Association Diabetes Risk Test in BIDMC, with improved predictive accuracy when combined. In normoglycaemic patients, AIRE-DM was superior to glycated haemoglobin (HbA1c) for predicting incident diabetes in BIDMC and non-inferior in ELSA-Brasil. The highest risk quartile reached 5% cumulative type 2 diabetes mellitus incidence 5.4 years (BIDMC) and 4.8 years (ELSA-Brasil) earlier than the lowest risk quartile, after adjusting for HbA1c, age, and sex. Phenome- and genome-wide association studies revealed biologically plausible associations with glucose regulation, cardiac morphology, diastolic dysfunction, arterial stiffness, and lipid metabolism. Conclusion: AI-ECG Risk Estimator for Diabetes Mellitus detects prevalent type 2 diabetes and predicts incident disease, uniquely identifying high-risk individuals within the normoglycaemic range. Combined with clinical scores or biomarkers, it enhances risk stratification, enabling earlier intervention.
- 22 July 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
- Vol. 7 (7)
Open AccessArtificial intelligence-enhanced electrocardiography for the prediction of future type 2 diabetes mellitus: a model-development and multicentre validation study
Aims: A significant proportion of type 2 diabetes cases remain undiagnosed despite screening advances, carrying substantial cardiometabolic risk. Artificial intelligence-enhanced electrocardiography (AI-ECG) detects subtle ECG changes in subclinical disease, potentially enabling opportunistic screening. Methods and results: We developed AI-ECG Risk Estimator for Diabetes Mellitus (AIRE-DM), a convolutional neural network with discrete-time survival loss, for diagnosis of prevalent and prediction of incident type 2 diabetes. It was trained on 1 163 401 ECGs from 189 537 individuals from Beth Israel Deaconess Medical Center (BIDMC) and externally validated in UK Biobank (UKB; n = 65 606) and ELSA-Brasil (n = 13 739). AI-ECG Risk Estimator for Diabetes Mellitus demonstrated moderate discrimination for prevalent type 2 diabetes (area under the receiver operating characteristic curve: BIDMC 0.724, UKB 0.733, ELSA-Brasil 0.706) and incident type 2 diabetes (C-index: BIDMC 0.667, UKB 0.688, ELSA-Brasil 0.625). The highest AIRE-DM risk quartile had elevated incident diabetes risk vs. the lowest (hazard ratio: BIDMC 4.75, UKB 7.52, ELSA-Brasil 3.96). AI-ECG Risk Estimator for Diabetes Mellitus was non-inferior to the American Diabetes Association Diabetes Risk Test in BIDMC, with improved predictive accuracy when combined. In normoglycaemic patients, AIRE-DM was superior to glycated haemoglobin (HbA1c) for predicting incident diabetes in BIDMC and non-inferior in ELSA-Brasil. The highest risk quartile reached 5% cumulative type 2 diabetes mellitus incidence 5.4 years (BIDMC) and 4.8 years (ELSA-Brasil) earlier than the lowest risk quartile, after adjusting for HbA1c, age, and sex. Phenome- and genome-wide association studies revealed biologically plausible associations with glucose regulation, cardiac morphology, diastolic dysfunction, arterial stiffness, and lipid metabolism. Conclusion: AI-ECG Risk Estimator for Diabetes Mellitus detects prevalent type 2 diabetes and predicts incident disease, uniquely identifying high-risk individuals within the normoglycaemic range. Combined with clinical scores or biomarkers, it enhances risk stratification, enabling earlier intervention.
- Open Access
- 2 June 2026
- Vol. 28 (6)
Atrial cardiomyopathy as a multidomain disease: longitudinal evidence for autonomic remodelling.
Atrial cardiomyopathy (AtCM) is increasingly recognized as a substrate for atrial fibrillation (AF), yet its operationalization remains limited and largely marker-driven. Whether autonomic remodelling represents a longitudinally evolving domain within a multidomain framework of AtCM remains unclear. To determine whether autonomic remodelling, assessed through static and longitudinal heart rate variability (HRV) abnormalities, defines a distinct domain of AtCM and contributes to atrial disease burden and clinical risk. We studied 670 individuals aged 65 years without prior AF or major cardiovascular disease from the prospective PROOF cohort with 24-h Holter ECGs at baseline and 5 years. Heart rate variability metrics, premature atrial contraction (PAC) burden, and left atrial (LA) size were assessed. Incident AF and cardiovascular outcomes were adjudicated over a median follow-up of 12.1 years. Seventy-two participants (10.7%) developed AF. Static HRV abnormalities and adverse 5-year HRV trajectories were independently associated with subsequent AF. Autonomic abnormalities showed limited concordance with PAC burden and LA enlargement, supporting their role as a distinct AtCM domain. Increasing involvement of remodelling domains was associated with higher risks of AF and cardiovascular outcomes. Participants with ≥2 domains exhibited higher risks of AF (HR 2.43; 95% CI 1.72-3.45), major adverse cardiovascular events (HR 1.42), and all-cause mortality (HR 1.35). Atrial cardiomyopathy is a cumulative, multidomain disease process in which structural, electrical, and autonomic abnormalities define atrial disease burden. Longitudinal autonomic remodelling constitutes an independent and evolving axis within this framework, shifting the focus from isolated arrhythmia detection towards progressive characterization of atrial substrate.
- 2 June 2026
- Vol. 28 (6)
Open AccessAtrial cardiomyopathy as a multidomain disease: longitudinal evidence for autonomic remodelling.
Atrial cardiomyopathy (AtCM) is increasingly recognized as a substrate for atrial fibrillation (AF), yet its operationalization remains limited and largely marker-driven. Whether autonomic remodelling represents a longitudinally evolving domain within a multidomain framework of AtCM remains unclear. To determine whether autonomic remodelling, assessed through static and longitudinal heart rate variability (HRV) abnormalities, defines a distinct domain of AtCM and contributes to atrial disease burden and clinical risk. We studied 670 individuals aged 65 years without prior AF or major cardiovascular disease from the prospective PROOF cohort with 24-h Holter ECGs at baseline and 5 years. Heart rate variability metrics, premature atrial contraction (PAC) burden, and left atrial (LA) size were assessed. Incident AF and cardiovascular outcomes were adjudicated over a median follow-up of 12.1 years. Seventy-two participants (10.7%) developed AF. Static HRV abnormalities and adverse 5-year HRV trajectories were independently associated with subsequent AF. Autonomic abnormalities showed limited concordance with PAC burden and LA enlargement, supporting their role as a distinct AtCM domain. Increasing involvement of remodelling domains was associated with higher risks of AF and cardiovascular outcomes. Participants with ≥2 domains exhibited higher risks of AF (HR 2.43; 95% CI 1.72-3.45), major adverse cardiovascular events (HR 1.42), and all-cause mortality (HR 1.35). Atrial cardiomyopathy is a cumulative, multidomain disease process in which structural, electrical, and autonomic abnormalities define atrial disease burden. Longitudinal autonomic remodelling constitutes an independent and evolving axis within this framework, shifting the focus from isolated arrhythmia detection towards progressive characterization of atrial substrate.
- Open Access
- 1 July 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (13) , e040814
Revisiting Abnormalities of Ventricular Depolarization: Redefining Phenotypes and Associated Outcomes Using Tree‐Based Dimensionality Reduction
Background: Abnormal ventricular depolarization, evident as a broad QRS complex on an ECG, is traditionally categorized into left bundle‐branch block (LBBB) and right bundle‐branch block or nonspecific intraventricular conduction delay. This categorization, although physiologically accurate, may fail to capture the nuances of diseases subtypes. Methods: We used unsupervised machine learning to identify and characterize novel broad QRS phenogroups. First, we trained a variational autoencoder on 1.1 million ECGs and discovered 51 latent features that showed high disentanglement and ECG reconstruction accuracy. We then extracted these features from 42 538 ECGs with QRS durations >120 milliseconds and employed a reversed graph embedding method to model population heterogeneity as a tree structure with different branches representing phenogroups. Results: Six phenogroups were identified, including phenogroups of right bundle‐branch block and LBBB with varying risk of cardiovascular disease and mortality. The higher risk right bundle‐branch block phenogroup exhibited increased risk of cardiovascular death (adjusted hazard ratio [aHR], 1.46 [1.30–1.63], P P P <0.05). Conclusions: Our findings challenge the current paradigm, highlighting the potential for these phenogroups to enhance cardiac resynchronization therapy patient selection for subjects with LBBB and guide investigation and follow‐up strategies for subjects with higher risk right bundle‐branch block.
- 1 July 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (13) , e040814
Open AccessRevisiting Abnormalities of Ventricular Depolarization: Redefining Phenotypes and Associated Outcomes Using Tree‐Based Dimensionality Reduction
Background: Abnormal ventricular depolarization, evident as a broad QRS complex on an ECG, is traditionally categorized into left bundle‐branch block (LBBB) and right bundle‐branch block or nonspecific intraventricular conduction delay. This categorization, although physiologically accurate, may fail to capture the nuances of diseases subtypes. Methods: We used unsupervised machine learning to identify and characterize novel broad QRS phenogroups. First, we trained a variational autoencoder on 1.1 million ECGs and discovered 51 latent features that showed high disentanglement and ECG reconstruction accuracy. We then extracted these features from 42 538 ECGs with QRS durations >120 milliseconds and employed a reversed graph embedding method to model population heterogeneity as a tree structure with different branches representing phenogroups. Results: Six phenogroups were identified, including phenogroups of right bundle‐branch block and LBBB with varying risk of cardiovascular disease and mortality. The higher risk right bundle‐branch block phenogroup exhibited increased risk of cardiovascular death (adjusted hazard ratio [aHR], 1.46 [1.30–1.63], P P P <0.05). Conclusions: Our findings challenge the current paradigm, highlighting the potential for these phenogroups to enhance cardiac resynchronization therapy patient selection for subjects with LBBB and guide investigation and follow‐up strategies for subjects with higher risk right bundle‐branch block.
- Open Access
- 11 May 2025
- Published by Elsevier in Heart Rhythm O2
- Vol. 6 (8) , 1097-1105
Granger causality connectivity analysis of persistent atrial fibrillation dynamics reveals posterior wall mechanistic insights
- 11 May 2025
- Published by Elsevier in Heart Rhythm O2
- Vol. 6 (8) , 1097-1105
Open AccessGranger causality connectivity analysis of persistent atrial fibrillation dynamics reveals posterior wall mechanistic insights
- Open Access
Hypertension and Atrial Fibrillation: Bridging the Gap Between Mechanisms, Risk, and Therapy
Background and objectives: Atrial fibrillation (AF), the most prevalent sustained arrhythmia, poses a significant public health challenge due to its links with stroke, heart failure, and mortality. Hypertension, a primary modifiable cardiovascular risk factor, is a well-established risk factor for AF that facilitates structural and electrical changes in the atria, including dilation, fibrosis, and pressure overload. Material and Methods: we conducted a literature search regarding the shared mechanisms, risks and treatments of hypertension and atrial fibrillation. Results: The renin–angiotensin–aldosterone system plays a pivotal role in this remodelling and inflammation, increasing AF susceptibility. Uncontrolled hypertension complicates AF management, diminishing the effectiveness of mainstay treatments, including antiarrhythmic drugs, catheter ablation, and cardioversion. Effective blood pressure management, particularly with therapies targeting the renin–angiotensin–aldosterone system (RAAS), can lower the risk of new-onset AF and reduce the incidence of recurrent AF, enhancing the success of rhythm control strategies. These antihypertensive therapies mitigate myocardial hypertrophy and fibrosis and attenuate both atrial pressure strain and the inflammatory response, mitigating the substrates for AF. Conclusion: This review highlights the urgent need for integrated strategies that combine BP control, AF screening, and lifestyle modifications to minimise the burden of AF and its complications. Future research should investigate the specific mechanisms of cellular-level interactions associated with a hypertensive predisposition to AF, including systematic inflammation and the role of genetics, the impact of blood pressure variations on AF risk, and individualised treatment strategies specifically targeting the shared mechanisms, simultaneously propagating hypertension and AF.
Open AccessHypertension and Atrial Fibrillation: Bridging the Gap Between Mechanisms, Risk, and Therapy
Background and objectives: Atrial fibrillation (AF), the most prevalent sustained arrhythmia, poses a significant public health challenge due to its links with stroke, heart failure, and mortality. Hypertension, a primary modifiable cardiovascular risk factor, is a well-established risk factor for AF that facilitates structural and electrical changes in the atria, including dilation, fibrosis, and pressure overload. Material and Methods: we conducted a literature search regarding the shared mechanisms, risks and treatments of hypertension and atrial fibrillation. Results: The renin–angiotensin–aldosterone system plays a pivotal role in this remodelling and inflammation, increasing AF susceptibility. Uncontrolled hypertension complicates AF management, diminishing the effectiveness of mainstay treatments, including antiarrhythmic drugs, catheter ablation, and cardioversion. Effective blood pressure management, particularly with therapies targeting the renin–angiotensin–aldosterone system (RAAS), can lower the risk of new-onset AF and reduce the incidence of recurrent AF, enhancing the success of rhythm control strategies. These antihypertensive therapies mitigate myocardial hypertrophy and fibrosis and attenuate both atrial pressure strain and the inflammatory response, mitigating the substrates for AF. Conclusion: This review highlights the urgent need for integrated strategies that combine BP control, AF screening, and lifestyle modifications to minimise the burden of AF and its complications. Future research should investigate the specific mechanisms of cellular-level interactions associated with a hypertensive predisposition to AF, including systematic inflammation and the role of genetics, the impact of blood pressure variations on AF risk, and individualised treatment strategies specifically targeting the shared mechanisms, simultaneously propagating hypertension and AF.
- Open Access
Granger causality connectivity analysis of persistent atrial fibrillation dynamics reveals mechanistic insights into the posterior wall
Background: Pulmonary vein isolation (PVI) is the mainstay of ablation for atrial fibrillation (AF). Adjunctive posterior wall isolation (PWI) has not demonstrated convincing additional benefit. To provide mechanistic underpinnings as to why empirical PWI does not improve outcomes, we undertook Granger Causality (GC) analysis of patient-specific AF dynamics before and after ablation. Methods: A prospective cohort study was undertaken at Royal Brompton Hospital. Consecutive patients undergoing PVI with left atrial electro-anatomical noncontact mapping (AcQmap; Acutus Medical) were included. GC analysis was undertaken before and after PVI but before adjunctive ablation. Results: In 21 consecutive patients, Causality Pairing Index, a Granger Causality-based measure of AF organisation, was unchanged post PVI; overall 0.087±0.012 vs. 0.086±0.015, p = 0.64, or by region (posterior wall; 0.084±0.020 vs 0.079±0.017, p = 0.20, rest of LA 0.087±0.013 vs 0.086±0.016, p = 0.80). Directional dispersion, quantifying conduction heterogeneity, was lower in the PW compared to the rest of the LA (0.093±0.036 vs 0.11±0.043, p = 0.017) and increased following PVI (0.093±0.036 vs 0.12±0.043, p = 0.045), while there was no change in the rest of the LA (0.11±0.034 vs 0.11±0.030, p =0.52). Net outflow for left atrial posterior wall decreased following PVI (pre −0.0086±0.047 vs −0.033±0.054, p=0.011), suggesting that in the majority of cases the posterior wall becomes a net sink after PVI Conclusion: We describe the first application of GC to global, simultaneous AF mapping data. GC analysis suggests, on average, the posterior wall is a net sink following PVI, and therefore PWI will not be beneficial in the majority of patients, providing mechanistic insight into null randomised control trials for PWI. GC is positioned as a valuable clinical decision tool to select the minority of patients that may benefit from PWI to guide personalised PsAF ablation strategies. Clinical Perspective: What is Known: Pulmonary vein isolation (PVI) is a standard treatment for atrial fibrillation (AF) ablation, but adjunctive posterior wall isolation (PWI) has not demonstrated consistent additional clinical benefit. What the Study Adds: Granger Causality analysis of AF dynamics indicates that, following PVI, the left atrial posterior wall becomes a net sink in most cases. This finding provides mechanistic insight into why PWI does not improve outcomes for most patients, explaining the null results in randomised trials. The study supports using Granger Causality as a decision tool to personalise ablation strategies, identifying the minority of patients who may benefit from PWI. Graphical
Open AccessGranger causality connectivity analysis of persistent atrial fibrillation dynamics reveals mechanistic insights into the posterior wall
Background: Pulmonary vein isolation (PVI) is the mainstay of ablation for atrial fibrillation (AF). Adjunctive posterior wall isolation (PWI) has not demonstrated convincing additional benefit. To provide mechanistic underpinnings as to why empirical PWI does not improve outcomes, we undertook Granger Causality (GC) analysis of patient-specific AF dynamics before and after ablation. Methods: A prospective cohort study was undertaken at Royal Brompton Hospital. Consecutive patients undergoing PVI with left atrial electro-anatomical noncontact mapping (AcQmap; Acutus Medical) were included. GC analysis was undertaken before and after PVI but before adjunctive ablation. Results: In 21 consecutive patients, Causality Pairing Index, a Granger Causality-based measure of AF organisation, was unchanged post PVI; overall 0.087±0.012 vs. 0.086±0.015, p = 0.64, or by region (posterior wall; 0.084±0.020 vs 0.079±0.017, p = 0.20, rest of LA 0.087±0.013 vs 0.086±0.016, p = 0.80). Directional dispersion, quantifying conduction heterogeneity, was lower in the PW compared to the rest of the LA (0.093±0.036 vs 0.11±0.043, p = 0.017) and increased following PVI (0.093±0.036 vs 0.12±0.043, p = 0.045), while there was no change in the rest of the LA (0.11±0.034 vs 0.11±0.030, p =0.52). Net outflow for left atrial posterior wall decreased following PVI (pre −0.0086±0.047 vs −0.033±0.054, p=0.011), suggesting that in the majority of cases the posterior wall becomes a net sink after PVI Conclusion: We describe the first application of GC to global, simultaneous AF mapping data. GC analysis suggests, on average, the posterior wall is a net sink following PVI, and therefore PWI will not be beneficial in the majority of patients, providing mechanistic insight into null randomised control trials for PWI. GC is positioned as a valuable clinical decision tool to select the minority of patients that may benefit from PWI to guide personalised PsAF ablation strategies. Clinical Perspective: What is Known: Pulmonary vein isolation (PVI) is a standard treatment for atrial fibrillation (AF) ablation, but adjunctive posterior wall isolation (PWI) has not demonstrated consistent additional clinical benefit. What the Study Adds: Granger Causality analysis of AF dynamics indicates that, following PVI, the left atrial posterior wall becomes a net sink in most cases. This finding provides mechanistic insight into why PWI does not improve outcomes for most patients, explaining the null results in randomised trials. The study supports using Granger Causality as a decision tool to personalise ablation strategies, identifying the minority of patients who may benefit from PWI. Graphical
- Open Access
- 27 April 2024
- Published by Elsevier in Clinical Infection in Practice
- Vol. 23, 100362
The prevalence and prognostic value of diabetes and hypertension in patients treated for cholera during the ongoing Syrian conflict
- 27 April 2024
- Published by Elsevier in Clinical Infection in Practice
- Vol. 23, 100362
Open AccessThe prevalence and prognostic value of diabetes and hypertension in patients treated for cholera during the ongoing Syrian conflict